InvestorsHub Logo

ClearlyStocks

08/07/13 10:29 AM

#428 RE: 1geb #427

This why I loaded up!

Larry Robbins' hedge fund Glenview Capital has disclosed a position in KV Pharmaceutical (KVPHQ). The firm filed Forms 3, 4, and 13D with the SEC regarding shares. Per the filings, Glenview has disclosed a 13.6% ownership stake in KVPHQ with 6,661,983 shares.

The filings show that they acquired shares between July 24th and August 2nd at prices ranging between $.2943 and $.5899. In August 2012, the company filed petitions for relief under Chapter 11 of the US Bankruptcy Code.

This guy just spent nearly $3 MILLION of his own money in the past week on this company. CH11 was in 2012.

If a hedge fund manager is willing to risk 3mil , ill risk a few k